Clinical trial
Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic…
NCT00323557 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00323557 |
|---|---|
| Title | Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients |
| Official title | Immuno-Augmentation With GM-CSF in Patients Receiving Pneumococcal Vaccine While Undergoing Treatment for Advanced Chronic Lymphocytic Leukemia (CLL) |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Bayer Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Biological, Drug |
| Interventions | Sargramostim (GM-CSF), Pneumococcal Vaccine |
| Enrollment | 39 |
| Start date | Jun 1, 2004 |
| Primary completion | May 1, 2011 |
| Completion | May 1, 2011 |
| First posted | May 9, 2006 |
| Last update posted | Dec 5, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: